CYP2D6 genotype and optimization of breast cancer treatment

被引：0
作者：
Bandres, F. [1 ]
Chicharro, L. M. [2 ]
Tejerina, A. [1 ]
del Saz, M. [2 ]
Fernaacutendez-Santander, A. [2 ]
机构：
[1] Fdn Tejerina, Unidad Docente, Madrid, Spain
[2] Univ Europea Madrid, Madrid, Spain
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70446-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [21] CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYP2D6
    MCLEOD, HL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 463 - 463
  • [22] Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
    Dezentje, Vincent O.
    Guchelaar, Henk-Jan
    Nortier, Johan W. R.
    van de Velde, Cornelis J. H.
    Gelderblom, Hans
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (01) : 15 - 21
  • [23] Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer
    Dezentje, V. O.
    Nortier, J. W. R.
    Guchelaar, H. J.
    van de Velde, C. J. H.
    Gelderblom, H.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 56 - 56
  • [24] Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
    Ramon y Cajal, T.
    Altes, A.
    Pare, L.
    del Rio, E.
    Alonso, C.
    Barnadas, A.
    Baiget, M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 33 - 38
  • [25] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [26] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    [J]. Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [27] The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen
    Stearns, V
    Hayes, DF
    Jin, Y
    Ullmer, L
    Nguyen, A
    Storniolo, AM
    Flockhart, U
    Desta, Z
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 5S - 5S
  • [28] CYP2D6 genotypes in Spanish women with breast cancer
    Ladona, MG
    Abildua, RE
    Ladero, JM
    Roman, JM
    Plaza, MA
    Agundez, JAG
    Munoz, JJ
    Benitez, J
    [J]. CANCER LETTERS, 1996, 99 (01) : 23 - 28
  • [29] CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer
    Berry, Donald
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (17): : 1267 - 1269
  • [30] CYP2D6 and tamoxifen: DNA matters in breast cancer
    Janelle M. Hoskins
    Lisa A. Carey
    Howard L. McLeod
    [J]. Nature Reviews Cancer, 2009, 9 : 576 - 586
12345